1. Trinchet JC, Beaugrand M. Augmentation de l’incidence du carcinome hépatocellulaire
dans les pays occidentaux. Quelles raisons et quelles conséquences ? Gastroenterol
Clin Biol 1999 ;23 :1286-8.
2. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs A, et al.
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000
EASL Conference. J Hepatol 2001 ;35 :421-30.
3. Chapoutot C, Perbey P, Fabre D, Taourel P, Bruel JM, Larrey D, et al. Essaimage
tumoraux sur le trajet de ponctions échoguidées de carcinomes hépatocellulaires.
Etude de 150 malades. Gastroenterol Clin Biol 1999 ; 23 : 552-6.
4. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzeti F, et
al. Liver transplantation for the treatment of small hepatocellular carcinomas
in patients with cirrhosis. N Engl J Med 1996 ; 334 : 693-9.
5. Michel P, Suc B, Montpeyroux F, Hachemanne S, Blanc P, Domergue J, et al.
Liver resection or transplantation for hepatocellular carcinoma ? J Hepatol
1997;26:1274-80.
6. Traissac L, Roudot-Thoraval F, Vanlemmens C, Conti F, Pageaux G, Chevret
S, et al. Gain de survie apporté par la transplantation hépatique chez les malades
transplantés pour carcinome hépatocellulaire. Gastroenterol Clin Biol 2001;25:A
159.
7. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection
versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann
Surg 1993 ;218 :145-51.
8. Llovet JM, Fuster J, Briux J for the Barcelona Clinic Liver Cancer (BCLC)
Group. Intention-to-treat analysis of surgical treatment for early hepatocellular
carcinoma : resection versus transplantation ; Hepatology1999 ;
30 : 1434-40.
9. Regimbeau JM, Farges O, Shen BY, Sauvanet A, Belghiti J. Is surgery for large
hepatocellular carcinoma justified ? J Hepatol 1999 ;31 :1062-8.
10. Grasso A, Watkinson AF, Tibballs JM, BurroughsAK. Radiofrequency ablation
in the treatment of heptocellular carcinoma. A clinical viewpoint. J Hepatol
2000; 33 : 667-72.
11. Castells A, Bruix J, Bru C, Fuster J, Vilana R, Navasa M, et al. Treatment
of small hepatocellular carcinoma in cirrhotic patients : a cohort study
comparing surgical resection and percutaneous ethanol injection. Hepatology
1993;18:1121-6.
12. Livraghi T, Bolondi L, Buscarini L, Cottone M, Mazziotti A, Morabito A,
et al. No treatment, resection and ethanol injection in hepatocellular carcinoma :
a retrospective analysis of survival in 391 patients with cirrhosis. Italian
Cooperative HCC Study Group. J Hepatol 1995;22:522-6.
13. Pelletier G, Roche A, Ink O, Anciaux ML, Derhy DS, Rougier P, et al. A
randomized trial of hepatic arterial chemoembolization in patients with unresectable
hepatocellular carcinoma. J Hepatol 1990;11:181-4.
14. GRETCH. A comparison of lipiodol chemoembolization and conservative treatment
for unresectable hepatocellular carcinoma. N Engl J Med 1995 ;332 :1256-61.
15. Pelletier G, Ducreux M, Gay F, Luboinski M, Hagege H, Dao T, et al. Treatment
of unresecable hepatocellular carcioma with lipiodol chemoembolization :
a multicenter randomized trial. J Hepatol 1998;29:129-34.
16. Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, et al. Arterial
embolisation or chemoembolisation versus symptomatic treatment in patients with
unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet
2002;359:1734-39.
17. Lo CM, Tso WK, Liu CL, Lam CM, Poon RTP, Fan ST, et al. Randomized controlled
trial of transarterial lipiodol chemoembolization for unresectable hepatocellular
carcinoma. Hepatology 2002;35:1164-71.
18. Bronowicki JP, Vetter D, Dumas F, Boudjema K, Bader R, Weiss AM, et al.
Transcatheter oily chemoembolization for hepatocellular carcinoma : a 4-year
study of 127 French patients. Cancer 1994;74:16-24.
19. Bruix J, Llovet JM, Castells A, Montana X, Bru C, Ayuso MDC, et al. Transarterial
embolization versus symptomatic treatment in patients with advanced hepatocellular
carcinoma : results of a randomized, controlled trial in a single institution.
Hepatology 1998;27:1578-83.
20. Raoul JL, Guyader D, Bretagne JF, Duvauferrier F, Bourguet P, Behkechi D,
et al. Randomized controlled trial for hepatocellular carcinoma with portal
vein thrombosis : intra-arterial iodine-131-iodized oil versus medical
support. J Nucl Med 1994;35:1782-7.
21. Lau WY, Leung TWT, Ho SKW, Chan M, Machin D, Lau J, et al. Adjuvant intra-arterial
iodine-131-labelled lipiodol for resectable hepatocellular carcinoma : a prospective
randomised trial. Lancet 1999;353:797-801.
22. Grimaldi C, Bleiberg H, Gay F, Messner M, Rougier P, Kok TC, et al. Evaluation
of antiandrogen therapy in unresectable hepatocellular carcinoma : results
of a European Organization for Research and Treatment of Cancer multicentric
double-blind trial. J Clin Oncol 1998;16:411-7.
23. GRETCH. Amulticenter randomized trial of anti-androgenic treatment (leuprorelin+flutamide+tamoxifen
vs tamoxifen) in patients with unresectable hepatocellular carcinoma (abstract).
Hepatology 1998; 28 : 249 A.
24. Castells A, Bruix J, Bru C, Ayuso C, Roca M, Boix L, et al. Treatment of
hepatocellular carcinoma with tamoxifen : a double-blind placebo controlled
trial in 120 patients. Gastroenterology 1995;109:917-22.
25. CLIP Group. Tamoxifen in treatment of hepatocellular carcinoma : a
randomised controlled trial. Lancet 1998;352:17-20.
26. Riestra S, Rodriguez M, Delgado M, Suarez A, Gonzalez N, de la Mata M, et
al. Tamoxifen does not improve survival of patients with advanced hepatocellular
carcinoma. J Clin Gastroenterol 1998;26:200-3.
27. Barbare JC, Milan C, Bouché O, Raoul JL, Bommelaer G, Rougier P et al.
Etude randomisée du tamoxifène dans le traitement palliatif du carcinome hépatocellulaire
: résultats de l’essai FFCD-ANGH 94-03 (abstract). Gastroenterol Clin Biol 2002
; 26 : A 129.
28. Kouroumalis E, Skordilis P, Thermos K, Vasilaki A, Moschandrea J, Manousos
ON. Treatment of hepatocellular carcinoma with octreotide : a randomised
controlled study. Gut 1998;42:442-7.
29. Yuen MF, Poon RTP, Lai CL, Fan ST, Lo CM, Wong KW, et al. A randomized placebo-controlled
study of long-acting octreotide for the treatment of advanced hepatocellular
carcinoma. Hepatology 2002;36:687-91.
30. Llovet JM, Sala M, Castells L, Suarez Y, Vilana R, Bianchi L, et al. Randomized
controlled trial of interferon treatment for advanced hepatocellular carcinoma.
Hepatology 2000;31:54-8.
31. Oldhafer KJ, Chavan A, Frühauf NR, Flemming P, Schlitt HJ, Kubicka S, et
al. Arterial chemoembolization before liver transplantation in patients with
hepatocellular carcinoma : marked tumor necrosis, but no survival benefit ?
J Hepatol 1998;29:953-9.
32. Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L, et al. Increased
risk of tumor seeding after percutaneous radiofrequency ablation for single
hepatocellular carcinoma. Hepatology 2001;33:1124-9.
33. Majno PE, Sarasin FP, Mentha G, Hadengue A. Primary liver resection and
salvage transplantation or primary liver transplantation in patients with single,
small hepatocellular carcinoma and preserved liver function: an outcome-oriented
decision analysis. Hepatology 2000;31:8996906.
34. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Gaik-Cheng Ooi C, Lai CL. Early detection
of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience.
Hepatology 2000;31:330-5.
35. Beaugrand M. Dépistage du carcinome hépatocellulaire sur cirrhose. Gastroenterol
Clin Biol 2000;24:B92-B94.
36. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, et al. Surveillance
programme of cirrhotic patients for early diagnosis and treatment of hepatocellular
carcinoma: a cost effectiveness analysis. Gut 2001;48:251-9.
37. Ganne-Carrié N, Chastang C, Chapel F, Munz C, Pateron D, Sibony M, et al.
Predictive score for the development of hepatocellular carcinoma and additionnal
value of large cell dysplasia in western patients with cirrhosis. Hepatology
1996;23:112-8.
38. Grando-Lemaire V, Guettier C, Chevret S, Beaugrand M, Trinchet JC, for the
GRETCH. Hepatocellular carcinoma without cirrhosis in the West: epidemiological
factors and histopathology of the non-tumotous liver. J Hepatol 1999;31:508-13.